Adicet Bio
ACET
101 hedge funds and large institutions have $425M invested in Adicet Bio in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 15 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 14
113% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 15
96% more call options, than puts
Call options by funds: $2.19M | Put options by funds: $1.11M
16% more funds holding
Funds holding: 87 → 101 (+14)
0.75% more ownership
Funds ownership: 5.19% → 5.94% (+0.75%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
33% less capital invested
Capital invested by funds: $630M → $425M (-$205M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$22.2M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$17.6M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$14.4M |
| 4 |
RI
RTW Investments
New York
|
+$13.2M |
| 5 |
CAC
Cowen and Company
New York
|
+$13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$62.3M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$5.49M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5M |
| 4 |
TLP
Tri Locum Partners
New York
|
-$4.66M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$3.92M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WP
101
Woodline Partners
San Francisco,
California
| – | -$3.92M | -12,282 | Closed |
|
|
EI
102
EAM Investors
Solana Beach,
California
| – | -$2.63M | -8,236 | Closed |
|
103
Invesco
Atlanta,
Georgia
| – | -$2.06M | -6,464 | Closed |
|
|
EGI
104
EAM Global Investors
Solana Beach,
California
| – | -$1.84M | -5,763 | Closed |
|
|
PVI
105
Pura Vida Investments
New York
| – | -$1.33M | -4,164 | Closed |
|
106
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | -$559K | -1,750 | Closed |
|
|
JGC
107
J. Goldman & Co
New York
| – | -$392K | -1,228 | Closed |
|
108
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$296K | -925 | Closed |
|
|
DWA
109
Dorsey Wright & Associates
Pasadena,
California
| – | -$70K | -218 | Closed |
|
110
Simplex Trading
Chicago,
Illinois
| – | -$16.9K | -77 | Closed |
|
111
UBS Group
Zurich,
Switzerland
| – | -$11K | -34 | Closed |
|
|
MCC
112
Money Concepts Capital
Palm Beach Gardens,
Florida
| – | -$3K | -9 | Closed |
|
113
US Bancorp
Minneapolis,
Minnesota
| – | -$2K | -5 | Closed |
|
|
LC
114
Lindbrook Capital
Calabasas,
California
| – | +$220 | +1 | New |
|
ACET Hedge Fund Activity: Q2 2022 in Review
101 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q2 2022, worth a combined $425M — down 33% from $630M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ACET positions and 15 closed out — a net gain of 17 holders — while 35 added to existing stakes and 14 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $22.2M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $62.3M sold.
- 101 institutional investors held Adicet Bio (ACET) as of Q2 2022, up from 87 in Q1 2022.
- Funds reported $425M of Adicet Bio stock for Q2 2022, down 33% quarter-over-quarter.
- 32 funds opened new Adicet Bio positions in Q2 2022 and 15 closed out, a net change of +17 holders.
- The largest Adicet Bio buyer in Q2 2022 was Morgan Stanley, an estimated $22.2M added.
- The largest Adicet Bio seller in Q2 2022 was Avidity Partners Management, an estimated $62.3M sold.
Based on aggregated 13F filings for Q2 2022.